Skip to content

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
Danaher logo
DanaherDHR
$1.09B+2.9%
Repligen logo
RepligenRGEN
$23.59M+106%
ADMA Biologics logo
ADMA BiologicsADMA
$55.71M+329%
Revvity logo
RevvityRVTY
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%

Valuation

See full
Market cap$849.64M+186%
Enterprise value$954.59M+182%
P/S4.2×+2.9×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s free cash flow?
Maravai LifeSciences Holdings, Inc. (MRVI) reported free cash flow of $4.23M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s free cash flow changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s free cash flow increased by 130.4% year-over-year, from -$13.89M to $4.23M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s free cash flow?
Over 2 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s free cash flow has grown at a -55.3% compound annual growth rate (CAGR), from $353.72M to -$70.72M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.